Seer Prevails in European Patent Opposition as U.S. ITC Opens Investigation into Nanomics
Seer announced that the European Patent Office has decided to maintain its patent EP4056263 covering particle-based enrichment, successfully defeating an opposition seeking revocation. Concurrently, the U.S. International Trade Commission instituted an investigation into Nanomics Biotechnology regarding the alleged infringement of five Seer patents, targeting Nanomics' Proteonano kits and workstations.
Key figures
- Patents infringed count
- 5
- Issued patents worldwide
- 84
- Patent applications total
- >250
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.